Anthem Blue Cross and Blue Shield New Hampshire prior authorization, page 55

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
G6013Radiation treatment delivery, three or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mevNew Hampshire Precertification List, Pg 231 Original policy
G6014Radiation treatment delivery, three or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20 mev or greaterNew Hampshire Precertification List, Pg 232 Original policy
G6015Intensity modulated treatment delivery, single or multiple fields/arcs, via narrow spatially and temporally modulated beams, binary, dynamic MLC, per treatment sessionNew Hampshire Precertification List, Pg 232 Original policy
G6016Compensator-based beam modulation treatment delivery of inverse planned treatment using three or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment sessionNew Hampshire Precertification List, Pg 232 Original policy
G6017Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (e.g., 3D positional tracking, gating, 3D surface tracking), each fraction of treatmentNew Hampshire Precertification List, Pg 232 Original policy
G9143Warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)New Hampshire Precertification List, Pg 232 Original policy
G9147Outpatient Intravenous Insulin Treatment (OIVIT) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (UUN); and/or, arterial, venous or capillary glucose; and/or potassium concentrationNew Hampshire Precertification List, Pg 232 Original policy
G9840RAS (KRAS and NRAS) gene mutation testing performed before initiation of anti- EGFR MoAbNew Hampshire Precertification List, Pg 232 Original policy
G9841RAS (KRAS and NRAS) gene mutation testing not performed before initiation of anti-EGFR MoAbNew Hampshire Precertification List, Pg 232 Original policy
H0004Behavioral health counseling and therapy, per 15 minutesNew Hampshire Precertification List, Pg 232 Original policy
H0006Alcohol and/or drug services; case managementNew Hampshire Precertification List, Pg 232 Original policy
H0015Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or educationNew Hampshire Precertification List, Pg 232 Original policy
H0017Behavioral health; residential (hospital residential treatment program), without room and board, per diemNew Hampshire Precertification List, Pg 233 Original policy
H0019Behavioral health; long-term residential (nonmedical, nonacute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diemNew Hampshire Precertification List, Pg 233 Original policy
H0023Behavioral health outreach service (planned approach to reach a targeted population)New Hampshire Precertification List, Pg 233 Original policy
H0035Mental health partial hospitalization, treatment, less than 24 hoursNew Hampshire Precertification List, Pg 233 Original policy
H0038Self-help/peer services, per 15 minutesNew Hampshire Precertification List, Pg 233 Original policy
H0039Assertive community treatment, face-to- face, per 15 minutesNew Hampshire Precertification List, Pg 233 Original policy
H0040Assertive community treatment program, per diemNew Hampshire Precertification List, Pg 233 Original policy
H2014Skills training and development, per 15 minutesNew Hampshire Precertification List, Pg 233 Original policy
H2019Therapeutic behavioral services, per 15 minutesNew Hampshire Precertification List, Pg 233 Original policy
H2020Therapeutic behavioral services, per diemNew Hampshire Precertification List, Pg 233 Original policy
H2021Community-based wrap-around services, per 15 minutesNew Hampshire Precertification List, Pg 234 Original policy
J0013Esketamine, nasal spray, 1 mgNew Hampshire Precertification List, Pg 234 Original policy
J0129Injection, abatacept, 10 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)New Hampshire Precertification List, Pg 234 Original policy
J0135Injection, adalimumab, 20 mgNew Hampshire Precertification List, Pg 234 Original policy
J0139Injection, adalimumab, 1 mgNew Hampshire Precertification List, Pg 234 Original policy
J0172Injection, aducanumab-avwa, 2 mgNew Hampshire Precertification List, Pg 234 Original policy
J0174Injection, lecanemab-irmb, 1 mgNew Hampshire Precertification List, Pg 234 Original policy
J0175Injection, donanemab-azbt, 2 mgNew Hampshire Precertification List, Pg 234 Original policy
J0177Injection, aflibercept HD, 1 mgNew Hampshire Precertification List, Pg 234 Original policy
J0178Injection, aflibercept, 1 mgNew Hampshire Precertification List, Pg 234 Original policy
J0179Injection, brolucizumab-dbll, 1 mgNew Hampshire Precertification List, Pg 234 Original policy
J0180Injection, agalsidase beta, 1 mgNew Hampshire Precertification List, Pg 234 Original policy
J0202Injection, alemtuzumab, 1 mgNew Hampshire Precertification List, Pg 234 Original policy
J0207Injection, amifostine, 500 mgNew Hampshire Precertification List, Pg 234 Original policy
J0208Injection, sodium thiosulfate (Pedmark), 100 mgNew Hampshire Precertification List, Pg 234 Original policy
J0217Injection, velmanase alfa-tycv, 1 mgNew Hampshire Precertification List, Pg 234 Original policy
J0218Injection, olipudase alfa-rpcp, 1 mgNew Hampshire Precertification List, Pg 234 Original policy
J0219Injection, avalglucosidase alfa-ngpt, 4 mgNew Hampshire Precertification List, Pg 234 Original policy
J0221Injection, alglucosidase alfa, (Lumizyme), 10 mgNew Hampshire Precertification List, Pg 234 Original policy
J0222Injection, patisiran, 0.1 mgNew Hampshire Precertification List, Pg 234 Original policy
J0223Injection, givosiran, 0.5 mgNew Hampshire Precertification List, Pg 234 Original policy
J0224Injection, lumasiran, 0.5 mNew Hampshire Precertification List, Pg 234 Original policy
J0225Injection, vutrisiran, 1 mgNew Hampshire Precertification List, Pg 234 Original policy
J0256Injection, alpha 1-proteinase inhibitor (human), not otherwise specified, 10 mgNew Hampshire Precertification List, Pg 234 Original policy
J0257Injection, alpha 1 proteinase inhibitor (human), (GLASSIA), 10 mgNew Hampshire Precertification List, Pg 234 Original policy
J0456Injection, azithromycin, 500 mgNew Hampshire Precertification List, Pg 234 Original policy
J0485Injection, belatacept, 1 mgNew Hampshire Precertification List, Pg 234 Original policy
J0490Injection, belimumab, 10 mgNew Hampshire Precertification List, Pg 234 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.